[Home ] [Archive]   [ فارسی ]  
Main Menu
Home::
Journal Information::
Archive ::
For Authors::
For Reviewers::
Ethical Code::
Subscription::
Contact us::
Peer Review Process::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 6 - ::
Ir J Physiol Pharmacol 2022, 6 - : 43-51 Back to browse issues page
The effect of tropisetron on expression of the pro-apoptotic factors in the rat model hypertrophic heart
Mahsa Fakhr Gholami , Fatemeh Safari , Alireza Karimollah *
Department of Pharmacology, School of Pharmacy, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran
Abstract:   (548 Views)
Background and Aim: Hypertension-induced left ventricular hypertrophy is an independent risk factor of heart failure and sudden death. Progression of cardiac hypertrophy is accompanied by activation of apoptosis signaling pathways. Tropisteron is a 5HT-3 receptor antagonist that its cardioprotective effects has been revealed by recent studies. Though, the underlying mechanisms are still unclear. The aim of the current study is to investigate the effect of tropisetron on gene expression of BNP (as the hypertrophy marker) and pro-apoptotic factors (BAD and BAX) in the rat model of hypertrophic heart.
Methods: Male Wistar rats (n = 24) were divided to the following groups: (I) control group including intact animals, (II) un-treated hypertrophy group (hypertrophy), (III) tropisetron-treated rats (3 mg/kg/day, 21 days)  during progression of hypertrophy (tropisetron + hypertrophy group), (IV) tropisetron-treated rats without induction of hypertrophy (tropisetron group). The left ventricular hypertrophy model was induced by surgical abdominal aortic banding. Gene expression was assessed by Real-time PCR.
Results: cardiac BNP mRNA level increased significantly in Hypertrophy group compared to the control (p < 0.001). In the tropisetron + hypertrophy group, BNP mRNA level was decreased significantly when compared with un-treated Hypertrophy group (p < 0.05). The transcription level of BAD was also upregulated in left ventricle of un-treated hypertrophy group (p < 0.001 vs. control). However, in the Tropisetron+Hypertrophy group, BAD mRNA level was decreased significantly compared to the untreated hypertrophy group (p < 0.001). The transcription level of BAX did not change significantly among the experimental groups.
Conclusion: Tropisetron can prevent the progression of pressure overload-induced hypertrophy to heart failure at least in part by decreasing BAD expression.
Keywords: Apoptosis, Tropisetron, Left ventricular hypertrophy, BAX, BAD, BNP ​​​​​​​
Full-Text [PDF 1223 kb]   (280 Downloads)    
Type of Study: Original Research | Subject: Cardiovascular System
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fakhr Gholami M, Safari F, Karimollah A. The effect of tropisetron on expression of the pro-apoptotic factors in the rat model hypertrophic heart. Ir J Physiol Pharmacol 2022; 6 :43-51
URL: http://ijpp.phypha.ir/article-1-553-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6 - Back to browse issues page
مجله فیزیولوژی و فارماکولوژی ایران Iranian Journal of Physiology and Pharmacology
Persian site map - English site map - Created in 0.06 seconds with 36 queries by YEKTAWEB 4645